Molecular cardiomyoplasty: Potential cardiac gene therapy for chronic heart failure
- 31 May 1995
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 109 (5) , 918-924
- https://doi.org/10.1016/s0022-5223(95)70317-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Congestive Heart Failure: Insights From Epidemiology, Implications for TreatmentMayo Clinic Proceedings, 1993
- The Incidence and Prevalence of Congestive Heart Failure in Rochester, MinnesotaMayo Clinic Proceedings, 1993
- Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors.Genes & Development, 1992
- Age-dependent ventricular response to pressure overloadThe Journal of Thoracic and Cardiovascular Surgery, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- MyoD family: a paradigm for development?Genes & Development, 1990
- Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD.Proceedings of the National Academy of Sciences, 1989
- Expression of a single transfected cDNA converts fibroblasts to myoblastsPublished by Elsevier ,1987
- Latissimus Dorsi as a Functioning Synchronously Paced Muscle Component in the Repair of a Left Ventricular AneurysmThe Annals of Thoracic Surgery, 1986
- MYOCARDIAL SUBSTITUTION WITH A STIMULATED SKELETAL MUSCLE: FIRST SUCCESSFUL CLINICAL CASEThe Lancet, 1985